TR199700791T1 - Kendiliğinden bağışıklığı olan hastalıkların ve allograft rejeksiyonun tedavisi için LCK SH2 spesifik bileşimlerinin kullanılması. - Google Patents

Kendiliğinden bağışıklığı olan hastalıkların ve allograft rejeksiyonun tedavisi için LCK SH2 spesifik bileşimlerinin kullanılması.

Info

Publication number
TR199700791T1
TR199700791T1 TR97/00791T TR9700791T TR199700791T1 TR 199700791 T1 TR199700791 T1 TR 199700791T1 TR 97/00791 T TR97/00791 T TR 97/00791T TR 9700791 T TR9700791 T TR 9700791T TR 199700791 T1 TR199700791 T1 TR 199700791T1
Authority
TR
Turkey
Prior art keywords
spontaneously
treatment
lck
allograft rejection
immune diseases
Prior art date
Application number
TR97/00791T
Other languages
English (en)
Turkish (tr)
Inventor
Damien Dunnington John
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR199700791T1 publication Critical patent/TR199700791T1/xx

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TR97/00791T 1995-02-10 1996-02-09 Kendiliğinden bağışıklığı olan hastalıkların ve allograft rejeksiyonun tedavisi için LCK SH2 spesifik bileşimlerinin kullanılması. TR199700791T1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38638195A 1995-02-10 1995-02-10

Publications (1)

Publication Number Publication Date
TR199700791T1 true TR199700791T1 (xx) 1998-03-21

Family

ID=23525357

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/00791T TR199700791T1 (xx) 1995-02-10 1996-02-09 Kendiliğinden bağışıklığı olan hastalıkların ve allograft rejeksiyonun tedavisi için LCK SH2 spesifik bileşimlerinin kullanılması.

Country Status (2)

Country Link
TR (1) TR199700791T1 (xx)
ZA (2) ZA961001B (xx)

Also Published As

Publication number Publication date
ZA961001B (en) 1996-08-13
ZA961000B (en) 1996-08-07
MX9706130A (es) 1997-11-29

Similar Documents

Publication Publication Date Title
EP1140170A4 (en) NOVEL AGENTS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF EYE DISORDERS
DK1654287T3 (da) CD20-bindende polypeptidsammensætninger
NO982062L (no) Humaniserte antistoff mot humant gp39, sammensetninger inneholdende dette, samt terapeutisk anvendelse derav
DE69527975D1 (de) Humanisierte antikörper gegen cd38
EA200000608A1 (ru) Предотвращение и лечение амилоидогенного заболевания
AU7573396A (en) Intraoral administration device and system
EP0671920A4 (en) AN ANTI-IDIOTYPICAL ANTIBODY AND ITS USE IN THE DIAGNOSIS AND THERAPY OF HIV-RELATED DISEASES.
LU92912I2 (fr) Mépolizumab et ses dérivés pharmaceutiquement acceptables (nucala)
IT1261949B (it) Composizione terapeutica a base di interferone umano, impiego di interferone umano in tale composizione e relativo metodo.
TR200202253T2 (tr) IL-18 Kaynaklı rahatsızlıkların tedavisinde faydalı rekombinant IL-18 antagonistleri
CA2023810A1 (fr) Compositions pharmaceutiques de type "pates a l'eau"
FR10C0016I2 (fr) Procedes et compositions s'appliquant au traitement de la glomerulonephrite
WO2004032868A3 (en) Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
ATE166464T1 (de) Verfahren und zusammensetzungen zur erhöhung des bild-kontrastes
DE69426767D1 (de) Anti idiotypische Antikörper gegen Gonococcen und diese verwendende Verfahren und Zusammensetzungen.
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
KR960030947A (ko) src SH2 특이성 화합물의 골흡수 질환 치료 용도
ATE442157T1 (de) Verwendung von anti-cd3 monoklonale antikírper und il-5 zur behandlung von autoimmunkrankheiten
ATE81467T1 (de) Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
TR199700791T1 (xx) Kendiliğinden bağışıklığı olan hastalıkların ve allograft rejeksiyonun tedavisi için LCK SH2 spesifik bileşimlerinin kullanılması.
ATE157010T1 (de) Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
ATE289819T1 (de) Gedächnissverbesserung durch verabreichung von delta-5-androsten-3-beta-ol-7,17-dion und 3-beta- estern desselben
DE69526102T2 (de) Verwendung von [r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo [2.2.2.] oct-3-yl) acetonitril zur hemmung der amyloid-beta-a4-bildung bei der alzheimerschen krankheit
DE69319341D1 (de) Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion
NO973659L (no) Anvendelse av LCK SH2-spesifikke forbindelser til behandling av autoimmune sykdommer og transplantatavvisning